136 related articles for article (PubMed ID: 6181552)
1. Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Vântu A; Bălănescu I; Stafidov N; Voiculeţ N
Med Interne; 1982; 20(2):151-5. PubMed ID: 6181552
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen and alpha fetoprotein levels in retinoblastoma.
Minei M; Yamana Y; Ohnishi Y
Jpn J Ophthalmol; 1983; 27(1):185-92. PubMed ID: 6190029
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract].
Tolino A; Di Serio C; Borruto Caracciolo G; Giamberini S; Montemagno U
G Ital Oncol; 1989; 9(2-3):63-6. PubMed ID: 2475441
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities of prognosis in cancer of the transverse colon and rectum using CEA, AFP and immunoglobulins A, M and G].
Smyslova VN
Vopr Onkol; 1987; 33(5):42-8. PubMed ID: 2438847
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
6. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
[TBL] [Abstract][Full Text] [Related]
8. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
Stratil P; Rejthar A; Lang BA; Kocent A; Pacovský Z; Matoska J
Neoplasma; 1988; 35(1):69-76. PubMed ID: 3352839
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
11. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
13. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
15. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
16. [An autopsied case of pulmonary blastoma with high serum alpha-fetoprotein and carcinoembryonic antigen levels].
Kiura K; Fujii M; Yamamoto Y; Moriwaki S
Gan No Rinsho; 1989 May; 35(6):729-34. PubMed ID: 2470930
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
18. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum alpha fetoprotein levels in postmenopausal women with primary breast carcinoma.
Sarcione EJ; Biddle W
Dis Markers; 1987 Jun; 5(2):75-9. PubMed ID: 2458881
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
